
Sign up to save your podcasts
Or
In this episode of The Harry Glorikian Show, host Harry Glorikian welcomes back Jeff Elton, CEO of Concert AI, to discuss the latest advancements in AI-driven healthcare solutions. They reflect on the recent JP Morgan Healthcare Conference, highlighting the optimism surrounding AI's role in transforming drug development and oncology. Jeff shares insights into Concert AI's innovative data ecosystems, partnerships, and the introduction of Kera, an AI platform designed to enhance clinical decision-making. The conversation also explores the challenges and opportunities in the evolving landscape of healthcare technology, emphasizing the importance of collaboration and adaptability in the face of rapid change.
Takeaways:
The JP Morgan Healthcare Conference indicated a positive outlook for the industry.
AI is becoming a central theme in healthcare discussions.
Concert AI is developing a comprehensive data ecosystem for oncology.
The introduction of agentic AI models is set to revolutionize data processing.
Collaboration with NVIDIA is enhancing Concert AI's capabilities.
Kera is a significant advancement in AI-driven healthcare solutions.
The future of drug development will rely heavily on AI and data analytics.
Healthcare organizations must adapt to the rapid pace of technological change.
Building partnerships is crucial for addressing healthcare fragmentation.
The integration of AI in clinical trials can significantly reduce timelines.
Chapters
00:00 The Annual Healthcare Pilgrimage
03:19 Optimism in the Pharma Industry
06:07 The Rise of AI in Healthcare
10:03 Concert AI's Evolution and Innovations
15:10 2024: A Standout Year for Concert AI
18:55 Balancing Growth and Innovation
22:33 Scaling Across Therapeutic Areas
26:26 The Future of Collaborations in Healthcare
28:37 Integrating Immune Status and Data Collaboration
31:04 Introducing Kera AI: The Future of Data Management
35:24 Innovations in Clinical Trials and Data Solutions
40:16 Rethinking Drug Development: Digital Twins and AI
42:36 Navigating Market Shifts and Talent Challenges
54:02 The Future of Concert AI and Healthcare Solutions
In this episode of The Harry Glorikian Show, host Harry Glorikian welcomes back Jeff Elton, CEO of Concert AI, to discuss the latest advancements in AI-driven healthcare solutions. They reflect on the recent JP Morgan Healthcare Conference, highlighting the optimism surrounding AI's role in transforming drug development and oncology. Jeff shares insights into Concert AI's innovative data ecosystems, partnerships, and the introduction of Kera, an AI platform designed to enhance clinical decision-making. The conversation also explores the challenges and opportunities in the evolving landscape of healthcare technology, emphasizing the importance of collaboration and adaptability in the face of rapid change.
Takeaways:
The JP Morgan Healthcare Conference indicated a positive outlook for the industry.
AI is becoming a central theme in healthcare discussions.
Concert AI is developing a comprehensive data ecosystem for oncology.
The introduction of agentic AI models is set to revolutionize data processing.
Collaboration with NVIDIA is enhancing Concert AI's capabilities.
Kera is a significant advancement in AI-driven healthcare solutions.
The future of drug development will rely heavily on AI and data analytics.
Healthcare organizations must adapt to the rapid pace of technological change.
Building partnerships is crucial for addressing healthcare fragmentation.
The integration of AI in clinical trials can significantly reduce timelines.
Chapters
00:00 The Annual Healthcare Pilgrimage
03:19 Optimism in the Pharma Industry
06:07 The Rise of AI in Healthcare
10:03 Concert AI's Evolution and Innovations
15:10 2024: A Standout Year for Concert AI
18:55 Balancing Growth and Innovation
22:33 Scaling Across Therapeutic Areas
26:26 The Future of Collaborations in Healthcare
28:37 Integrating Immune Status and Data Collaboration
31:04 Introducing Kera AI: The Future of Data Management
35:24 Innovations in Clinical Trials and Data Solutions
40:16 Rethinking Drug Development: Digital Twins and AI
42:36 Navigating Market Shifts and Talent Challenges
54:02 The Future of Concert AI and Healthcare Solutions